Atlas Trials

Daniel Keizman

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Daniel Keizman

RecordFirmDate
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors (NCT07485114)Daniel Keizman2025-12-03

Track Daniel Keizman automatically

Every clearance here is in the API, with alerts when new ones post.